BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 35606022)

  • 1. Patients' and their caregivers' experiences with regular, low-dose, sustained-release morphine for chronic breathlessness associated with COPD: a qualitative study.
    Ferreira D; Kochovska S; Honson A; Phillips J; Currow D
    BMJ Open Respir Res; 2022 May; 9(1):. PubMed ID: 35606022
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The impact of regular, low-dose, sustained-release morphine for chronic breathlessness on caregiver burden: An exploratory analysis of the BEAMS trial.
    Kochovska S; Ferreira D; Chang S; Luckett T; Roydhouse J; Ekström M; Currow DC
    Palliat Med; 2024 Jan; 38(1):156-162. PubMed ID: 37978419
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A pragmatic, phase III, multisite, double-blind, placebo-controlled, parallel-arm, dose increment randomised trial of regular, low-dose extended-release morphine for chronic breathlessness: Breathlessness, Exertion And Morphine Sulfate (BEAMS) study protocol.
    Currow D; Watts GJ; Johnson M; McDonald CF; Miners JO; Somogyi AA; Denehy L; McCaffrey N; Eckert DJ; McCloud P; Louw S; Lam L; Greene A; Fazekas B; Clark KC; Fong K; Agar MR; Joshi R; Kilbreath S; Ferreira D; Ekström M;
    BMJ Open; 2017 Jul; 7(7):e018100. PubMed ID: 28716797
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Morphine for chronic breathlessness in COPD: improvement predictors-cross-sectional study.
    Verberkt CA; van den Beuken-Everdingen MHJ; Schols JMGA; Wouters EFM; Janssen DJA
    BMJ Support Palliat Care; 2024 Jan; 13(e3):e829-e832. PubMed ID: 35850961
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Morphine for the symptomatic reduction of chronic breathlessness: the case for controlled release.
    Currow DC; Kochovska S; Ferreira D; Johnson M
    Curr Opin Support Palliat Care; 2020 Sep; 14(3):177-181. PubMed ID: 32740277
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oral modified release morphine for breathlessness in chronic heart failure: a randomized placebo-controlled trial.
    Johnson MJ; Cockayne S; Currow DC; Bell K; Hicks K; Fairhurst C; Gabe R; Torgerson D; Jefferson L; Oxberry S; Ghosh J; Hogg KJ; Murphy J; Allgar V; Cleland JGF; Clark AL
    ESC Heart Fail; 2019 Dec; 6(6):1149-1160. PubMed ID: 31389157
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chronic breathlessness in advanced cardiorespiratory disease: patient perceptions of opioid use.
    Moran T; Zentner D; Wong J; Philip J; Smallwood N
    BMJ Support Palliat Care; 2023 Dec; 13(e2):e334-e343. PubMed ID: 33837113
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modified-release morphine or placebo for chronic breathlessness: the MABEL trial protocol.
    Date K; Williams B; Cohen J; Chaudhuri N; Bajwah S; Pearson M; Higginson I; Norrie J; Keerie C; Tuck S; Hall P; Currow D; Fallon M; Johnson M
    ERJ Open Res; 2023 Jul; 9(4):. PubMed ID: 37583966
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low-Dose Morphine Does Not Cause Sleepiness in COPD: A Secondary Analysis of a Randomized Trial.
    Altree TJ; Toson B; Loffler KA; Ekström M; Currow DC; Eckert DJ
    Am J Respir Crit Care Med; 2024 Mar; ():. PubMed ID: 38477675
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Maintenance of non-pharmacological strategies 6 months after patients with chronic obstructive pulmonary disease (COPD) attend a breathlessness service: a qualitative study.
    Luckett T; Roberts M; Swami V; Smith T; Cho JG; Klimkeit E; Wheatley JR
    BMJ Open; 2021 May; 11(5):e050149. PubMed ID: 33986071
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Perspectives of patients, family caregivers and physicians about the use of opioids for refractory dyspnea in advanced chronic obstructive pulmonary disease.
    Rocker G; Young J; Donahue M; Farquhar M; Simpson C
    CMAJ; 2012 Jun; 184(9):E497-504. PubMed ID: 22529167
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Morphine use for cancer pain: A strong analgesic used only at the end of life? A qualitative study on attitudes and perceptions of morphine in patients with advanced cancer and their caregivers.
    Ho JFV; Yaakup H; Low GSH; Wong SL; Tho LM; Tan SB
    Palliat Med; 2020 May; 34(5):619-629. PubMed ID: 32103707
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Breathlessness and opioid prescribing in COPD in general practice: a cross-sectional, observational study.
    Currow DC; Johnson MJ; Pollack A; Ferreira DH; Kochovska S; Ekström M; Harrison C
    ERJ Open Res; 2020 Apr; 6(2):. PubMed ID: 32775398
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Opioid therapy for refractory dyspnea in patients with advanced chronic obstructive pulmonary disease: patients' experiences and outcomes.
    Rocker GM; Simpson AC; ; Horton R; Sinuff T; Demmons J; ; Hernandez P; Marciniuk D
    CMAJ Open; 2013 Jan; 1(1):E27-36. PubMed ID: 25077099
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The lived experience of breathlessness and its implications for care: a qualitative comparison in cancer, COPD, heart failure and MND.
    Gysels MH; Higginson IJ
    BMC Palliat Care; 2011 Oct; 10():15. PubMed ID: 22004467
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Opioids in Treatment of Refractory Dyspnea in Chronic Obstructive Pulmonary Disease: Yes, No or Maybe.
    Rajnoveanu RM; Harangus A; Todea DA; Man MA; Budin CE; Rajnoveanu AG
    J Pers Med; 2024 Mar; 14(3):. PubMed ID: 38541060
    [TBL] [Abstract][Full Text] [Related]  

  • 17. How Physicians in South India Recognize, Assess, and Manage People with Chronic Breathlessness Syndrome: A Thematic Analysis.
    Barnes-Harris MM; Daniel S; Venkateswaran C; Hutchinson A; Johnson MJ
    Indian J Palliat Care; 2021; 27(1):54-61. PubMed ID: 34035618
    [TBL] [Abstract][Full Text] [Related]  

  • 18. What potentially treatable opportunistic mould could be the cause of the patients' breathlessness?
    Brunke S; Hunter LD; Mnguni AT
    Afr J Thorac Crit Care Med; 2024; 30(1):30. PubMed ID: 38756388
    [No Abstract]   [Full Text] [Related]  

  • 19. Effect of Regular, Low-Dose, Extended-release Morphine on Chronic Breathlessness in Chronic Obstructive Pulmonary Disease: The BEAMS Randomized Clinical Trial.
    Ekström M; Ferreira D; Chang S; Louw S; Johnson MJ; Eckert DJ; Fazekas B; Clark KJ; Agar MR; Currow DC;
    JAMA; 2022 Nov; 328(20):2022-2032. PubMed ID: 36413230
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.